skip to Main Content

Medical Mutual of Ohio Medical Policy Updates – June 2018

Click here to view the Medical Mutual of Ohio Medical Policy Updates » June 2018 Medical Policy Updates: Crysvita® (burosumab-twza) Ryplazim™ (plasminogen) Investigational Experimental Services Not Eligible for Reimbursement Kevzara  (sarilumab) Kymriah (tisagenlecleucel) suspension for IV infusion Leuprolide long-acting Oncology…

Read More
Back To Top